📞 88558 10010 (Silver Leaf Clinic) 📞 +91 20 6768 9704 (Landline) 📞 84118 08284 (Direct / WhatsApp)
Silver Leaf Clinic · Hadapsar, Pune
Home›Conditions›Rectal Cancer
Colorectal Cancer · Rectal Cancer Surgery · Pune

Rectal Cancer Surgery & Sphincter Preservation

Robotic TME · LAR · ISR · Avoid a Permanent Colostomy

Most rectal cancer patients — including those with low rectal tumours — can avoid a permanent colostomy through robotic, sphincter-preserving surgery. Dr. Vinod T. Gore performs Robotic Total Mesorectal Excision (TME), Low Anterior Resection (LAR) and Intersphincteric Resection (ISR) with nerve-sparing precision.

Sphincter Preservation — Most Cases Robotic TME · da Vinci Xi FARIS Edinburgh No Permanent Bag — Most Patients
Book a Consultation See surgical options →
Dr. Vinod T. Gore
90%+
Sphincter preserved in suitable cases
3.7%
Local recurrence with proper TME
300+
Robotic procedures by Dr. Gore
90–95%
Stage I cure rate
Understanding Rectal Cancer

What is rectal cancer?

The rectum is the final 12–15 cm of the large bowel, just before the anus. Rectal cancer usually begins as a polyp on the lining that slowly becomes cancerous over years. What makes it different from colon cancer is its location deep in the narrow pelvis — surrounded by the sphincter muscles, the bladder and the delicate nerves that control continence and sexual function.

This is why the surgeon’s experience matters so much in rectal cancer. The goal is not only to remove the cancer completely, but to do so while preserving the sphincter (avoiding a permanent bag) and protecting those nerves. Robotic surgery is particularly suited to this confined space.

Rectal cancer is among the most common GI cancers in India and is increasingly seen in adults under 50. When detected early it is highly curable — screening colonoscopy from age 45, or sooner if symptoms appear, is essential.

Key Facts
12–15
Centimetres — the length of the rectum, deep in the pelvis
90%+
Patients in whom the sphincter can be preserved in suitable cases
90–95%
Cure rate when found at Stage I
MRI
Pelvic MRI is mandatory to stage every rectal cancer
45
Age to begin screening (earlier with symptoms or family history)
Causes & Risk Factors

What causes rectal cancer?

Most rectal cancers are sporadic — they arise by chance over years, usually from a polyp. A combination of factors raises the risk; many of them are within your control.

Age
Risk rises after 50, though rectal cancer is increasingly seen in younger adults.
Diet
High intake of red and processed meat, with low fibre, raises risk.
Obesity & inactivity
Excess weight and a sedentary lifestyle increase the risk.
Smoking
Long-term smoking is linked to colorectal cancer.
Alcohol
Regular heavy alcohol use increases risk.
Inflammatory bowel disease
Long-standing ulcerative colitis or Crohn’s disease raises risk.
Family history
A close relative with colorectal cancer or polyps increases risk.
Hereditary syndromes
Lynch syndrome (HNPCC) and FAP carry a high inherited risk.
Previous polyps / diabetes
Prior adenomatous polyps and type 2 diabetes are associated with higher risk.

The good news: diet, weight, smoking and alcohol are modifiable, and screening from age 45 can catch cancer — or pre-cancerous polyps — early, when treatment is simplest and most successful.

Warning Signs

Symptoms of rectal cancer

Never ignore rectal bleeding or a lasting change in bowel habit. These need prompt evaluation — early rectal cancer is highly curable.

Rectal bleeding, or blood in or on the stool
A persistent change in bowel habit — looser, harder or narrower stools — lasting over 4 weeks
A feeling of incomplete emptying after passing stool (tenesmus)
Unexplained weight loss
Pelvic or lower abdominal pain or cramping
Tiredness and iron-deficiency anaemia
Many early rectal cancers cause no symptoms — and bleeding is often wrongly blamed on piles. Any rectal bleeding deserves proper assessment; screening from age 45 is the most reliable safeguard.
Disease Staging

Rectal cancer stages & outlook

A pelvic MRI is mandatory for staging — it shows how deep the tumour goes and its relationship to the mesorectal fascia (the key surgical margin), which guides whether chemoradiation is needed before surgery.

StageClassificationDescription5-yr Survival
Stage I
T1–T2, N0, M0Confined to the rectal wall. Surgery alone is usually curative.90–95%
Stage II
T3–T4, N0, M0Grown through the wall but no lymph nodes involved. Chemoradiation often given before surgery.75–85%
Stage III
Any T, N1–N2, M0Spread to nearby lymph nodes. Chemoradiation followed by TME surgery.50–75%
Stage IV
Any T, Any N, M1Spread to liver, lung or peritoneum. Combined systemic therapy and surgery for selected patients.Variable
Treatment Pathway

From diagnosis to recovery

Rectal cancer often needs treatment before surgery, not just an operation — every step is decided together at the tumour board.

01
Step 01
Staging & MDT
Pelvic MRI (mandatory), CT chest/abdomen/pelvis and CEA. Every case is presented to the multidisciplinary tumour board.
02
Step 02
Neoadjuvant Therapy
For T3/T4 or node-positive tumours, chemoradiation (5–6 weeks) or short-course radiotherapy shrinks the tumour, lowers recurrence and can enable sphincter preservation.
03
Step 03
Restaging
A repeat MRI 6–8 weeks later assesses response. A few complete responders may be offered ‘watch and wait’; most proceed to surgery.
04
Step 04
Robotic TME Surgery
Robotic LAR, ISR or APR depending on tumour height and sphincter involvement, with nerve-sparing dissection throughout.
05
Step 05
Pathology Review
Mesorectal completeness, circumferential margin (CRM), node count and tumour regression are reviewed; adjuvant chemo planned if needed.
06
Step 06
Stoma Reversal
Any temporary ileostomy is reversed once the join has healed — usually after 2–3 months.
Surgical Treatment · Sphincter Preservation

Removing the cancer — and keeping you whole

Preserving the sphincter and natural bowel function is a primary goal for every rectal cancer patient at Silver Leaf Clinic. With robotic surgery, Dr. Gore achieves sphincter preservation in the majority of patients — including many with very low tumours.

Gold Standard · All Rectal Cancer
Robotic Total Mesorectal Excision (TME)
Nerve-Sparing · The Foundation of Rectal Cancer Surgery

TME is the single most important principle in rectal cancer surgery — removing the entire mesorectal envelope (the fatty package of tissue and lymph nodes around the rectum) intact, along the correct embryological plane. Pioneered by Professor Bill Heald, TME reduced local recurrence from 30–38% to under 5%. Performed robotically, the magnified 3D view and wristed instruments allow precise nerve-sparing dissection deep in the pelvis — protecting the bladder and sexual function that open surgery often compromises, and achieving a clear circumferential margin (CRM) in the vast majority.

Mid & Low Rectal · Sphincter Preserved
Low Anterior Resection (LAR)
Removes the cancerous rectum and rejoins the bowel to the anal canal, preserving the sphincter and natural bowel function. A temporary loop ileostomy usually protects the join and is reversed after 2–3 months.
  • Sphincter preserved — natural bowel function
  • Temporary ileostomy reversed at 2–3 months
  • The standard sphincter-preserving operation
  • No permanent bag for most patients
Very Low Rectal · Avoids Permanent Stoma
Intersphincteric Resection (ISR)
The most advanced sphincter-preserving operation, for cancers within 1–2 cm of the sphincter. The inner sphincter is removed with the tumour while the outer sphincter is preserved, maintaining continence — avoiding a permanent colostomy even for very low tumours.
  • Avoids a permanent colostomy for very low tumours
  • Inner sphincter removed, outer preserved
  • Continence maintained in most patients
  • Feasible robotically in most anatomies
When the Sphincter Is Involved
Abdominoperineal Resection (APR)
Removes the rectum and the sphincter and creates a permanent end colostomy. APR is reserved for the minority of tumours that directly invade the sphincter and cannot be removed with a clear margin while preserving function.
  • Only when the tumour invades the sphincter
  • Always reviewed at the tumour board first
  • Permanent stoma with full expert support
  • Robotic or open with meticulous dissection
Robotic Pelvic Surgery

Why robotic surgery suits the pelvis

The rectum sits deep in a narrow bony pelvis — especially in men and heavier patients. Open surgery means working at depth through a long incision; straight laparoscopic instruments struggle to angle around the pelvic floor. The da Vinci robot was, in many ways, built for exactly this space.

3D magnified vision
Ten-times magnified, true-depth 3D view of the pelvis — far beyond the human eye or a 2D laparoscope.
Wristed instruments
Instruments that bend and rotate like a human wrist reach around corners deep in the pelvis where straight laparoscopic tools cannot.
Tremor filtration
The system filters natural hand tremor and steadies the camera for precise, controlled dissection.
Nerve-sparing
Greater precision helps preserve the pelvic nerves — protecting urinary and sexual function.
More sphincter preservation
The reach and control make sphincter preservation possible for low tumours that might otherwise need a permanent bag.
ICG fluorescence
Real-time fluorescence checks blood supply to the join, helping reduce the risk of an anastomotic leak.
The Evidence

Robotic rectal surgery — what the trials show

Minimally-invasive surgery is now well established as oncologically safe for rectal cancer, with faster recovery than open surgery. For the narrow pelvis specifically, a growing body of randomised evidence supports the robotic approach.

Total Mesorectal Excision (TME)
Heald · The Foundation
Before TME, local recurrence after rectal cancer surgery was 30–38%. Professor Heald’s TME technique cut 5-year local recurrence to about 3.7% and lifted disease-free survival to around 80% — making TME the global standard.
REAL Trial
Lancet Gastroenterol Hepatol, 2022
A large multicentre randomised trial of robotic vs laparoscopic surgery for middle and low rectal cancer. Robotic surgery gave better oncological quality (more complete resection, lower positive-margin rate, more lymph nodes), fewer conversions to open (1.7% vs 3.9%), fewer complications (16% vs 23%) and faster recovery.
ROLARR Trial
JAMA, 2017
The first major randomised trial of robotic vs laparoscopic rectal surgery. Conversion and pathology were comparable overall, but the benefit of robotics was clearest in technically difficult cases — the male pelvis, low tumours and higher BMI — and grew with surgeon robotic experience.
COLRAR Trial
Annals of Surgery, 2023
In patients treated with chemoradiation, robotic and laparoscopic surgery achieved similar complete-TME rates, while robotic surgery achieved a higher rate of clear circumferential margins (100% vs 93.9%).
Meta-analysis of RCTs
Langenbeck’s Archives of Surgery, 2024
Pooling 15 randomised trials, robotic rectal surgery had a significantly lower conversion-to-open rate than laparoscopy, with comparable complication rates.
Functional Outcomes
Multiple studies
Robotic TME is consistently linked to better preservation of urinary and sexual function, attributed to superior nerve-sparing in the pelvis.

References: Heald RJ (Br J Surg). REAL trial — Feng Q et al., Lancet Gastroenterol Hepatol 2022;7:991–1004. ROLARR — Jayne D et al., JAMA 2017;318:1569–1580. COLRAR — Park JS et al., Ann Surg 2023. This information is educational and does not replace a personal consultation.

Understanding Your Stoma

Temporary vs permanent stoma

Most rectal cancer patients who have sphincter-preserving surgery need only a temporary stoma — or none at all. A permanent stoma is reserved for the minority whose tumour involves the sphincter.

After LAR or ISR · Reversed at 2–3 Months
Temporary Loop Ileostomy
Protects the new bowel join while it heals, then reversed in a short second procedure once a contrast study confirms healing.
After APR · Only When Sphincter Involved
Permanent End Colostomy
Needed only when the sphincter has been removed with the tumour. Full counselling and a specialist stoma nurse support you throughout.
💬

No one faces a stoma unprepared. A specialist stoma nurse provides counselling before surgery — covering siting, home care, diet, clothing, travel and reversal planning — and ongoing support afterwards.

Patient Questions

Frequently asked questions — rectal cancer

Will I definitely need a permanent colostomy bag?+

In most cases, no. Through robotic LAR or ISR, the majority of rectal cancer patients keep natural bowel function. A temporary ileostomy may protect the join for 2–3 months and is then reversed. A permanent colostomy (APR) is only needed when the tumour directly invades the sphincter — a minority of patients, and only after careful tumour-board review.

What is Total Mesorectal Excision (TME)?+

TME removes the entire mesorectal package — the fatty envelope of tissue and lymph nodes around the rectum — intact, along the correct anatomical plane. It reduced rectal cancer local recurrence from over 30% to under 5% and is now the mandatory standard. Robotic TME allows this with excellent nerve-sparing precision.

Why is robotic surgery especially good for rectal cancer?+

The rectum lies deep in the narrow pelvis, hardest to reach in men and heavier patients. The robot’s 3D magnified vision and fully-wristed instruments are ideally suited to this confined space — enabling nerve-sparing dissection and sphincter preservation that can be difficult by open or standard keyhole surgery. Trials such as REAL show better margins, fewer conversions and faster recovery.

Will I need chemotherapy or radiotherapy before surgery?+

Often, yes, for Stage II–III rectal cancer. Chemoradiation (5–6 weeks) or short-course radiotherapy before surgery shrinks the tumour, lowers the chance of local recurrence, and can make sphincter preservation possible where it otherwise would not be.

What is ‘watch and wait’?+

A small number of patients whose tumour completely disappears after chemoradiation may be offered close surveillance instead of immediate surgery, with surgery kept in reserve if the tumour returns. It is only suitable for confirmed complete responders and needs rigorous follow-up.

How long is recovery after rectal cancer surgery?+

With robotic surgery, most patients are walking within 24 hours, eating within 2–3 days, and home in 5–7 days, with full recovery over 6–8 weeks. Any ileostomy reversal is a shorter procedure 2–3 months later.

Book a Consultation

Rectal cancer consultation, Pune

Bring your pelvic MRI, CT scan and biopsy report. Dr. Gore reviews everything personally and gives you a clear, honest picture of your options — including every sphincter-preservation possibility.

📞
Silver Leaf Clinic
88558 10010
 ☎️
Silver Leaf Clinic Landline
+91 20 6768 9704
 📱
Dr. Gore Direct / WhatsApp
84118 08284
Silver Leaf Clinic
511, City Centre, Solapur Road, Opp. Vaibhav Theatre, Hadapsar, Pune 411028
📍 Open in Google Maps
OPD Hours
Monday – Saturday10:00 AM – 6:00 PM
SundayBy Appointment
Also See
Robotic GI Surgery Sphincter Preservation → Stoma Care & Reversal